ait logo
The AIT Austrian Institute of Technology is a strong partner for innovation in the fields of health and environment. Our experts develop new findings and implement them in innovative technologies and solutions. The Health & Environment Department provides scientific support to national and international research partners from industry and public institutions.

One of our main research areas is “sensing life” including the development of bio- and nanosensor systems, such as biochips for medical diagnostics.

In our biochip activities we cover all steps of biochip technologies, like development of surface chemistries, design of oligonucleotide probes, arraying, protein assay development, strategies for signal enhancement, assay validation and data analysis. Recently oligonucleotide chips for pathogen detection and protein biomarker chips for diagnosis of sepsis and prognosis of melanoma have been successfully realized.
Partner details
Regarding the Biosensors & System integration research more information can be found at  

Regarding the Micro&Nano Technology Laboratories more information can be found at 

Logo Allergy Cancer BioNanoResearchCentre  Logo UniSalzburg

The  Allergy-Cancer-BioNano Research Centre of the University of Salzburg comprises twelve research groups focusing on the topics allergy, immunology, cancer research, nanotoxicity and structural biology. Investigation of the molecular and cellular basis of different diseases serves as the common denominator.

Performance of excellent basic science and translational research with high international visibility and recognition are the declared aims of the priority programme.

 Brimatech Logo RGB L neu
BRIMATECH is a privately owned SME based in Vienna. It supports R&D in industry, SMEs and other organizations. BRIMATECH facilitates the development of new fields of business by specific market research and tailored business development activities. Our focus is on strategic and operative services for technology-intensive markets. These services include:
• market analysis and analysis of the innovation environment
• assessment of innovations from a market- and user perspective
• initiation and management of R&D projects and market introductions
BRIMATECH’s target groups include national and international research and development consortia, public bodies (especially policy decision makers with a strong focus on technology), research organizations, industry, and start-up companies.
In addition to longstanding experience of the BRIMATECH team in high-tech marketing, R&D support and international business development, the company is characterized by its technology-orientation, methodological know-how and the extensive, international network.
Donauuni Krems
The Department of Health Sciences and Biomedicine provides highly specialised post-graduate study programmes in selected medical disciplines and strives for research excellence in biomedical technology and regenerative medicine. The department aspires to be market leader for continuing education in health services management, future-oriented technologies such as nanomedicine and bioinformatics, all aspects of clinical medicine with special emphasis on internal medicine, regenerative medicine including orthopaedics, sports medicine and complementary medicine.
Research activities are focused on developing and strengthening the department’s internationally recognised position with regard to advancing extracorporeal blood purification systems in collaboration with strategic partners, as well as R&D in regenerative medicine, particularly in the field of muscular-skeletal systems and cellular therapy and diagnostics.
Besides, the Department of Health Sciences and Biomedicine meets the challenge of combining clinical research on the therapeutic effectiveness of conventional medicine with methods of TCM and complementary medicine– aiming at promoting evidence based practice and an evidence based approach for the latter.

PTB logo ID 6294

Ongoing from recently collected knowledge about the underlying mechansims of the lectin-cell interaction, the Smart Drug Delivery & Preclinical Pharmaceutics-group develops and evaluates labelled and surface-functionalized micro- and nanoparticles made from biodegradable polymers as well as soluble macromolecular prodrug-systems. Besides optimisation of manufacturing parameters special emphasis is given to the particle-cell interaction. The currently established human cell culture models comprise artificial intestinal epithelium, prostate cancer, bladder and bladder cancer, breast-carcinoma, chondrocytes, macrophages, vascular endothelial cells as well as primary cultures.

Currently, research efforts focus on development of innovative bioadhesive formulations for therapy of urinary tract infections and bladder cancer as well as systems for drug delivery to the middle and the inner ear. At this, the approaches rely on specially designed constructs considering the type of cargo, the charge, and the surface-decoration.

Within the BioNanoNet IPB offers the technological development of particulate matter and its physico-chemical, nanotoxicological as well as preclinical characterisation.






Climate change, water pollution, and soil contamination cause global and local variations to the environment. It is our responsibility to deal carefully and economically with available resources. To predict hazards that endanger the anthroposphere requires modern and innovative tools, and prevention implies the employment of ecologically sustainable and effective measures.

Within the scope of the BOKU - areas of competence Soil - Ecosystems and Water - Climate - Environment, the Institute of Waste Management generates innovative programs, methods, and procedures for

• closing of natural and anthropogenic cycles
• proper low-emission treatment of waste materials
• monitoring and remediation of environmental damages
• sustainable integration of ultimately landfilled waste materials in the cultural landscape

We are geared towards natural processes. Understanding of the natural scientific background advances our expertise in the field of application.

Lectures concentrate on communication of the appropriate use of both resources and products and of the critical analysis of political targets in waste management, with particular reference to their ecological and economical effects.

The manifold network of competences available at the BOKU - University provides a wide possibility of partnership, unique in Austria.

genspeed biotech logo
GENSPEED Biotech GmbH was founded in October 2016 as a spin-off of Greiner Bio-One. We develop, produce and distribute rapid tests based on the IVD-CE certified GENSPEED® technology.
With a novel combination of microfluidics, miniaturized optical detection and automation, GENSPEED® allows for the first time to detect a multiple of parameters simultaneously and with high sensitivity at the point of care (POC) in just a few minutes.
GENSPEED® can be used for nucleic acid-based tests, ie genetic tests for the rapid determination of bacteria or viruses, and at the same time allows for protein-based testing with precise quantification of different biomarkers from blood or other specimen.
GENSPEED® offers:
  • GENSPEED® HAI test portfolio enabling fast and cost-efficient detection of antibiotic resistant infections at hospital labs and thus protecting patients from these dangerous bugs 
  • PerioPOC® to provide the dentists and periodontologists with a tool for rapid diagnosis and therapy in periodontal disease
  • GENSPEED®, a universal point-of-care testing OEM platform, enabling fast, reliable and accurate test results at the point of need.
GENSPEED® - fast results to drive decisions

Paracelsus universitaet salzburg

There is a growing socio-economic need for effective and reproducible strategies to repair musculoskeletal tissues. In particular, acute tendon injuries and chronic tendinopathies remain clinically challenging, partly due to the low number of tissue-resident cells. Further, the avascular nature of tendons delays healing, whilst the innate reparative processes are incomplete and are often associated with the formation of scar tissue that compromises mechanical function and causes pain. In contrast, bone generally is effectively repaired after damage through an innate regenerative process, in most cases resulting in full restoration of a functional tissue with no apparent scar formation. However, around 10% of all fractures do not heal adequately and especially large osseous defects after trauma, prosthesis loosening, or tumor resection, remain clinically challenging.

Despite significant advancements in regenerative medicine and tissue engineering (e.g. sophisticated combination of scaffolds, cells, and biologics) the clinical impact for the regeneration of tendon and bone remains limited. For the development of functional reparative therapies, we need to pin down the molecular and cellular mechanisms amenable to modulate endogenous (or exogenous) cell behavior towards functional repair and regeneration. By investigating the developmental programs driving tendon and bone tissue formation and, on the other hand, the mechanisms contributing to their senescence, ultimately resulting in decreased quality of tendons and bones in the elderly, novel targets for clinical intervention potentially can be discovered.

logo umit 4c

The Institute of Electrical and Biomedical Engineering was founded as an academic unit at the Department of Biomedical Informatics and Mechatronics in September 2009. The goal of the Institute of Electrical and Biomedical Engineering (former Institute of Electrical, Electronic and Bioengineering) is to advance fundamental understanding of how electrical and biomedical systems operate and to develop effective technologies for applications across a wide spectrum in mechatronics and biomedical engineering.

Collaborations with international research institutions and industry offer unique opportunities for the electrical and biomedical engineering discipline. Located at the UMIT/EWZ campus in Hall in Tyrol, the institute does have strong local collaborations with the Leopold-Franzens University Innsbruck, the Innsbruck Medical University and the Tyrolean industry.


The ITA deals with the impacts of new technologies on society, the environment and the economy. It carries out scientific technology assessment (TA) on a variety of topics.The results of this work support policy-makers, administration and the public with regard to issues of technology policy.

  • With our research, we seek to better understand the societal relevance of technology and to develop TA methodology further
  • We develop options and recommendations for decision-makers in politics, the public sector and the general public
Current Research Focuses

The scientific work of the ITA is carried out within the framework of our Medium-Term Research Programme, which is updated each year. Currently the ITA has the following research focuses:

Logo LBI Ludwig Boltzmann ID 4234

The Ludwig Boltzmann Institute for Experimental and Clinical Traumatology has been the core of the Austrian Cluster for Tissue Regeneration since 2006 which was further enlarged in 2013/2014 (see our information brochures at the attachment). The Research Center is located in the Lorenz Böhler Trauma Center in Vienna, Austria. In 2003, a satellite laboratory was established in Linz, Upper Austria, devoted to human adult stem cell research; the laboratory operates in conjunction with the Red Cross Bloodbank of Upper Austria.

The primary objective of the Center for Traumatology Research is to improve diagnostic and therapeutic measures in  trauma care specifically in the area of intensive care (Prof. Soheyl Bahrami) and tissue regeneration (Prof. Heinz Redl). Interdisciplinary cooperation allows the Center to be engaged in many fields of medicine, stemming not only from diverse research projects, but also analysis of international research results and their practical application within the AUVA (clinical studies and Continuing Education). Furthermore, the Research Center is involved in numerous Austrian and European research projects

Messerli Research Institute Logo ID 3897       logo muw     logo vetmed

Head: Prof. Erika Jensen-Jarolim, MD The research unit represents a strong bridge from human to veterinary medicine. Accordingliy the team is active at two universities:

1.) Laboratory of Comparative Medicine , located at the University of Veterinary Medicine Vienna, and

2.) Laboratory of Comparative Immunology and Oncology, Medical University Vienna

More than 40 scientists work today in the laboratories. The development of novel vaccines agains allergies and cancer is in the focus of research, with special emphasis on nanotechnology. Laboratory 1 was opened in spring 2013 only and is best equipped not only with standard device, but also high-end devices such as the automated laser scanning microscope Tissue FAXs from Tissue Gnostics, Vienna, a Becton Dickinson FACS Canto II equipped with the latestsoftware and two lasers, an ISAC ImmunoCAP microchip scanner for molecular allergy diagnosis. Methods comprise biochemical and immunological Assays, immunohistochemistry, protein and antibody expression and purification, as well as all state of the art in vitro methods in allergy and cancer research.


Univ.Prof. Dr. Erika Jensen-Jarolim,, phone: +43 1 40400 51100

Mrs. Regina Meixner,, phone: +43 (664) 60257 - 6263 Mrs. Nora Diallo,, phone: +43 (1) 40400 - 51200


The Chair of Polymer Processing at the Montanuniversitaet Leoben is an internationally recognized research institution working in the field of polymer engineering and science. The five key aspects of activity are i) injection molding, ii) extrusion and compounding, iii) polymer nanocomposites and nanotechnology, iv) rheological and thermodynamic material properties and v) simulation. The chair addresses issues that treat current basic as well as applied research, such as nanotechnology, polymeric paper, waste utilization, energy savings, process optimization, product development, quality control, and questions on the wear of metallic materials in the processing machines and molds. For the execution of research projects various laboratory as well as semi-industrial scale machinery, such as injection molding machines or single and twin-screw extruders, as well as fully equipped laboratories for material data evaluation and simulation are available. The Chair of Polymer Processing with its human resources and facilities is able to perform complex state of the art research in the field of polymer engineering and science as well as related, e.g. medical engineering or pharmacology, industry and research topics.


The Industrial Liaison Department is the contact point for companies and business relation at the Montanuniversitaet Leoben. The focus of its activities lies on finding solutions for industrial problems and research challenges related to the expertise and research areas of the Montanuniversitaet. Networking and establishing cooperations between company partners, research institutions and the departments of the Montanuniversitaet are the main tasks of the members of the Industrial Liaison Department. Additional expertise lies in the definition and management of R&D projects, the consulting in funding issues, questions of IPR management or entrepreneurship.   The Industrial Liaison Department offers together in cooperation with the Technology Academy of the Montanuniversitaet highly specialised lifelong learning and training in the field of frontier engineering topics.

Norganoid logo

Enhancing Future Neurosciences

NORGANOID is a startup that is supported by the high tech incubator Science Park Graz. We are currently working on a device for engineering brain orgnaids and screening drugs more efficiently.

Our research areas and field of interest include 3D Organ-On-Chip Solutions with emphasis on:

  • Human Stem Cell Technology
  • Brain Degeneration
  • Microfluidic Systems
  • Nano Solutions

Stem cells hold great biological capacities that also allow to engineer human tissue structures. Brain organoids derived from stem cells mimic the three dimensional architecture of the Central Nervous System and therefore are suitable for studying and modeling neurological diseases. These organoids are of high therapeutic interest as they can be used for testing pharmaceutical products. It is even possible to generate brain organoids based on patient's body cells which enables personalized medicine. 

Logo Profactor ID 3318

PROFACTOR is a private, applied research company with headquarters in Steyr and Vienna.
Our scientists research and develop industrial production technologies. The Society to promote the modernization of production technologies in Austria (Vereinigung zur Förderung der Modernisierung der Produktionstechnologie in Österreich or VPTÖ for short) founded PROFACTOR in 1995. In April 2014, the Upper Austrian Research (UAR) has taken over 60 percent of the shares of PROFACTOR GMBH. More than 1,240 completed projects with more than 400 satisfied partners and customers have made us to Austria’s no. 1 in applied production research. 

ProspectiveInstruments logo

Prospective Instruments provides photonic-based multi-modal imaging and analytical solutions for research, life science and clinical care.

Economic – Compact – Flexible – Modular
Advanced multimodal imaging in a compact, easy to use and affordable package. No need for optical table or specially equipped laboratory environment. No installations or alignments by trained personnel required. Unpack – plug in – image.

Prospective Instruments also provides customized multimodal microscopes to our partners. We collaborate with various institutions for initial trials and use cases.